JAK2 and acute lymphoblastic leukemia: There have also been some rare activating JAK2 mutations identified in ALL that localize to the JAK2 kinase domain (Mullighan et al., 2009c; Marty et al., 2014; Sadras et al., 2017; Hammaren et al., 2019b).